Jeremy Grantham Johnson & Johnson Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 6,294,037 shares of JNJ stock, worth $964 Million. This represents 3.25% of its overall portfolio holdings.
Number of Shares
6,294,037
Previous 6,024,386
4.48%
Holding current value
$964 Million
Previous $881 Million
15.84%
% of portfolio
3.25%
Previous 3.01%
Shares
30 transactions
Others Institutions Holding JNJ
# of Institutions
4,270Shares Held
1.68BCall Options Held
17.6MPut Options Held
14.5M-
Vanguard Group Inc Valley Forge, PA231MShares$35.4 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$30.3 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.6 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.59 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.91 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $400B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...